experimental group:Evolocumab and standard treatment

2 trials

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Ningbo First Hospital

Conditions

Acute myocardial infarctionacute coronary syndrome

Phase 4

A prospective, multicenter, randomized, controlled study of early use of PCSK9 inhibitors and early reduction of LDL-Cholesterol levels on cardiovascular outcomes in Chinese patients with acute coronary syndrome

Active, not recruitingChiCTR2000032111

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universityacute coronary syndrome

Start: 2020-06-01Updated: 2021-08-30

The treatment of PCSK9 inhibitor in catheter room for acute myocardial infarction: a randomized controlled study

Active, not recruitingChiCTR2200059319

Ningbo First HospitalAcute myocardial infarction

Start: 2022-04-28Updated: 2024-02-26